08:52 AM EDT, 06/11/2024 (MT Newswires) -- Health care stocks were leaning lower premarket Tuesday, with the Health Care Select Sector SPDR Fund (XLV) inactive and the iShares Biotechnology ETF (IBB) down 0.4%.

Viridian Therapeutics ( VRDN ) stock was up over 6% after the company said it would begin two late-stage clinical trials to evaluate VRDN-003 in patients with active and chronic thyroid eye disease in August.